Rates of tympanic membrane closure in double-tympanocentesis studies
- PMID: 18449065
- DOI: 10.1097/INF.0b013e3181674133
Rates of tympanic membrane closure in double-tympanocentesis studies
Abstract
Background: Data on the outcome of tympanic membrane (TM) closure after tympanocentesis in acute otitis media (AOM) patients is limited.
Objectives: To analyze the dynamics of TM perforation closure after 1 or 2 tympanocentesis procedures performed at diagnosis and during AOM treatment.
Patients and methods: Study population included 113 children enrolled in 4 double-tympanocentesis studies. Only the files of patients whose first and second examination were performed by the same 2 otorhinolaryngologists were analyzed. Middle ear fluid (MEF) was cultured on day 1 and days 4-6, the latter only in initially culture-positive patients. Patients were also examined on days 11-14 and followed until days 22-28.
Results: Ninety-three (82%) patients underwent tympanocentesis on days 4-6; 103 (91%) and 95 (84%) were evaluable on days 11-14 and 22-28, respectively. One hundred seventy-three ears underwent tympanocentesis on day 1 and 139 on days 4-6. Ninety-seven (86%) patients had positive MEF cultures. One hundred fifty-three (88%) tympanocentesis procedures performed at enrollment were closed on days 4-6. No differences were recorded in the closure rates as function of patient age, previous AOM history, MEF culture positivity, pathogens isolated at enrollment, and pathogen eradication on days 4-6. The 20 eardrums still open on days 4-6 were closed on days 11-14. Eleven (9%) of the evaluable ears tapped on days 4-6 were not closed on days 11-14 and 9 of 10 were closed on days 22-28.
Conclusions: TM perforation closed in most cases within a few days regardless of patient and disease characteristics, and 2 consecutive tympanocentesis procedures performed at short-time intervals are associated with good TM closure rates.
Similar articles
-
Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen.Pediatr Infect Dis J. 2003 Mar;22(3):209-16. doi: 10.1097/01.inf.0000066798.69778.07. Pediatr Infect Dis J. 2003. PMID: 12634580
-
A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection.Pediatr Infect Dis J. 2006 Mar;25(3):211-8. doi: 10.1097/01.inf.0000202138.12950.3c. Pediatr Infect Dis J. 2006. PMID: 16511382 Clinical Trial.
-
Epidemiologic and microbiologic characteristics of culture-positive spontaneous otorrhea in children with acute otitis media.Pediatr Infect Dis J. 2009 May;28(5):381-4. doi: 10.1097/INF.0b013e318194e783. Pediatr Infect Dis J. 2009. PMID: 19319018
-
Comparison of study designs for acute otitis media trials.Int J Pediatr Otorhinolaryngol. 2008 Jun;72(6):737-50. doi: 10.1016/j.ijporl.2008.02.020. Epub 2008 Apr 8. Int J Pediatr Otorhinolaryngol. 2008. PMID: 18400312 Review.
-
Predictive value of double tympanocentesis in acute otitis media.Pharmacotherapy. 2005 Dec;25(12 Pt 2):105S-10S. doi: 10.1592/phco.2005.25.12part2.105S. Pharmacotherapy. 2005. PMID: 16305279 Review.
Cited by
-
Systemic corticosteroids for acute otitis media in children.Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012289. doi: 10.1002/14651858.CD012289.pub2. Cochrane Database Syst Rev. 2018. PMID: 29543327 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical